RevaTis

Revatis is a Spin-off from the University of Liège. It was created in 2013 and is dedicated to regenerative medicine and cell therapy.

The growth of Revatis is supported by its innovative and patented technology to obtain pluripotent adult mesenchymal stem cells from a minimally invasive muscle micro-biopsy

The company focuses mainly on horses but also owns a licence in human medicine.